$NBIX
Neurocrine Biosciences Inc
XNAS•Health Care•Biological Products, (No Diagnostic Substances)
$146.10
▼-0.19%-$0.280
Subscriptions are live. Early access $24.99/mo, or start with 5 free premium days.
Plans & pricingDonateNeurocrine Biosciences Inc
XNAS•Health Care•Biological Products, (No Diagnostic Substances)
Why is NBIX down today? It is at $146.10 (-0.19%), and our scanner flagged it 81 times on unusual volume this month. See the catalyst behind the move, real-time alerts the moment NBIX spikes, and full due diligence on NBIX — key stats, earnings, dilution and insider activity. Free.
Our scanner flagged $NBIX 81 times in the last 30 days. Create a free account to track $NBIX, build a watchlist, and get instant unusual-volume alerts, with a full day of premium now and 5 more when you verify your email, no card needed.
No card · 5 premium days · join 800+ traders
The top plays and unusual-volume catches our scanner flags, emailed to you. No account needed.
No spam. Unsubscribe anytime. Not investment advice.
NBIX is one of today's most active names, trading on unusually heavy volume (live price and day move above). Our scanner has fired 6 unusual-volume and momentum alerts on NBIX today, peaking at 13.2x its normal volume. A recent catalyst in the news: “Here's Why Neurocrine Biosciences (NBIX) is a Strong Growth Stock.” Early read: bullish.
Likely catalystExecutive / Board Change, from an SEC filing. Read it →Latest filing144Notice of proposed insider sale (144)Oct 30, 2026 · todaySources: float & market cap via Polygon · short interest via FINRA · borrow & shortability via Alpaca · SSR from Reg SHO 201 · filings & dilution via SEC EDGAR · analysts via Nasdaq.
Auto-generated from public data for research and education. Not investment advice.
| Insider | Action | Shares | % of position | Owns after | Value | Date |
|---|---|---|---|---|---|---|
Abernethy Matt Officer | Sold (automatic/other) | -2K | sold 5.1% | 43K | $363K at $157.20 | Sep 14, 26 |
Boyer David W. Officer | Sold (automatic/other) | -826 | sold 8.7% | 9K | $130K at $157.45 | Sep 14, 26 |
Abernethy Matt Officer | Acquired (grant/award) | +5K | added 12% | 48K | n/a | Sep 11, 26 |
Abernethy Matt Officer | Sold (automatic/other) | -3K | sold 5.7% | 45K | $423K at $156.22 | Sep 11, 26 |
Benevich Eric Officer | Acquired (grant/award) | +6K | added 9.7% | 71K | n/a | Sep 11, 26 |
Benevich Eric Officer | Sold (automatic/other) | -3K | sold 4.8% | 67K | $529K at $156.22 | Sep 11, 26 |
Boyer David W. Officer | Acquired (grant/award) | +4K | added 45% | 11K | n/a | Sep 11, 26 |
Boyer David W. Officer | Sold (automatic/other) | -2K | sold 17% | 10K | $302K at $156.22 | Sep 11, 26 |
Cooke Julie Officer | Acquired (grant/award) | +4K | added 16% | 26K | n/a | Sep 11, 26 |
Cooke Julie Officer | Sold (automatic/other) | -2K | sold 7.5% | 24K | $302K at $156.22 | Sep 11, 26 |
Delaet Ingrid Officer | Acquired (grant/award) | +4K | added 28% | 21K | n/a | Sep 11, 26 |
Delaet Ingrid Officer | Sold (automatic/other) | -2K | sold 12% | 18K | $378K at $156.22 | Sep 11, 26 |
Recent Form-4 filings via Nasdaq. Open-market buys are the signal worth watching. Grants and automatic (10b5-1) sells are routine. “% of position” is the share of that insider’s own holding the trade moved. Not investment advice.
Blend of news sentiment, today’s move, and community votes. Not investment advice.
News, unusual-volume alerts, AI-trader trades and community chatter - the whole story, newest first.
The tickers our scanner is lighting up most over the last 48 hours.
Comparable names in biological products, (no diagnostic substances), closest in size first.
NBIX is one of today's most active names, trading on unusually heavy volume (live price and day move above). Our scanner has fired 6 unusual-volume and momentum alerts on NBIX today, peaking at 13.2x its normal volume. A recent catalyst in the news: “Here's Why Neurocrine Biosciences (NBIX) is a Strong Growth Stock.” Early read: bullish.
NBIX last traded at $146.10, down 0.19% on the day. The price and chart above update live during market hours (4 AM to 8 PM ET).
Neurocrine Biosciences Inc (NBIX) is next expected to report earnings on Monday, November 2, 2026 (after close), about 3 days away. Earnings reports often cause large overnight gaps, so many traders manage risk around the date. The date can shift until the company officially confirms it.
The NBIX Live Alerts panel on this page streams real-time unusual volume (RVOL), momentum, halt and 200-EMA alerts from our scanner the moment they fire. Our scanner has flagged NBIX 81 times in the last 30 days.
NBIX (Neurocrine Biosciences Inc) trades on XNAS, with a market cap of about $14.85B in the BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) sector.
That depends on your strategy and risk. Day traders look for volume, volatility and a clear trend. Use the live chart, RVOL alerts and 200-EMA context on this page to judge NBIX for yourself. This is not investment advice.
Live data from TheDesperateTrader scanner. Not investment advice.
$NBIX discussion
Sign in to ask a question or join the discussion.